5-Amino-1MQ (5-amino-1-methylquinolinium) is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme expressed in adipose tissue and other metabolically active organs that catalyzes the methylation of nicotinamide using S-adenosylmethionine as the methyl donor. NNMT activity has been linked to cellular energy regulation, NAD+ biosynthesis, and the epigenetic programming of fat cell development, making it a subject of considerable interest in metabolic research.
NNMT Pathway Research
Preclinical studies have examined 5-Amino-1MQ for its capacity to inhibit NNMT enzymatic activity, thereby influencing downstream NAD+ metabolism and one-carbon pathway flux. Research published in Nature Communications examined NNMT inhibition in adipose tissue models and its relationship to mitochondrial biogenesis and thermogenic gene expression in experimental settings.
Metabolic Pathway Modulation
Research in rodent models has explored the compound's interactions with AMPK signaling and its influence on lipid metabolism regulation. Studies have examined changes in adipocyte size and differentiation markers in experimental models treated with NNMT inhibitors under controlled laboratory conditions.
NAD+ Biosynthesis Interactions
As NNMT competes with the Preiss-Handler pathway for nicotinamide substrate, its inhibition has been studied in the context of intracellular NAD+ availability and sirtuin enzyme activation. Research models have examined how NNMT inhibition influences SIRT1 activity and downstream transcriptional regulation in metabolic tissues.
• Kraus D et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature, 508(7495), 258–262.
• Hong S et al. (2015). Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine, 21(8), 887–894.
